The rising prevalence of acute ischemic stroke cases is driving the global demand for both diagnostic and surgical procedures in acute stroke treatment. Technological advancements in surgical procedures, along with a rising ageing population, increased demand for minimally invasive procedures, and growth in health care spending is the other major factors driving the growth of the global acute ischemic stroke diagnosis and treatment market. Excessive usage of medication for the treatment of ischemic stroke and the high cost of surgical procedures are hindering the growth of the market.
Key Market Trends The Computerized Tomography (CT) Segment Led the Global Market in 2018
Imaging studies are used in ischemic diagnosis for the detection of haemorrhage in the acute stroke patient, in order to assess the degree of brain injury and to identify the vascular lesion responsible for the ischemic deficit.
Some advanced CT and MRI technologies are able to distinguish between brain tissue that is irreversibly infarcted and that which is potentially salvageable, thereby allowing better selection of patients likely to benefit from therapy.
In 2018, the leading diagnostic segment was computed tomography. The highest share of CT techniques is attributable to widespread access and speed of acquisition. In the hyperacute phase, a non-contrast CT (NCCT) scan is usually ordered to exclude or confirm haemorrhage; it is highly sensitive for this indication.
North America Holds the Largest Market Share
By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle-East & Africa (MEA), and South America. North America is the largest market for acute ischemic stroke diagnosis devices and is estimated to continue its stronghold of the market, owing to favourable government initiatives, technological innovations, and increasing demand for ischemic stroke products.
Asia-Pacific is expected to be the fastest-growing market for acute ischemic stroke diagnosis, owing to the increasing incidences of ischemic stroke cases in the region. Manufacturers are expanding their operations in the Asia-Pacific region, as these regions hold immense potential for market growth.
Competitive Landscape The leading vendors of acute ischemic stroke diagnosis products are expanding their operations in Asian countries (India, China, Japan, and South Korea), as these economies hold immense potential for acute ischemic stroke diagnosis and treatment products. Major players operating in the global acute ischemic stroke diagnosis and treatment market include Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, GE Healthcare, Hitachi Ltd, Nihon, Kohden Corporation, Canon Medical Systems Corporation and Koninklijke Philips NV are among Others
Reasons to Purchase this report: - The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Our reports have been used by over 10K customers, including:
The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug...
The ASEAN lifestyle-related disease supplements market studied was valued at USD 4,103.61 million in 2020, and it is projected to register a CAGR of 9.94% during the forecast period (2021-2026). The COVID-19 has increased the demand of various lifestyle-related disease supplements in the region on account of growing awareness and increasing...
The global wearable injectors market is projected to reach USD 11.5billion by 2026 from USD 7.2billion in 2021, at a CAGR of 9.9% during the forecast period. Growth in this market is mainly driven by factors such as the shift of healthcare delivery toward homecare due to COVID-19, advantages of wearable injectors in the administration of various...
The oxidative stress assay market is projected to reach USD 1,326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%. Growth in the oxidative stress assay market can be attributed to growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of...
Certain factors that are driving the market growth include rising healthcare expenditure, growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide. According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately...
The major factors attributing to the growth of the biosurgery market are increasing geriatric population, rising prevalence of chronic diseases and related surgeries, and a strong focus on R&D leading to the launch of new and advanced products. The global increase in the number of geriatrics population and obese people is likely to...
The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages,...
The Nitinol Medical Devices Market is expected to register a CAGR of 9.1% over the forecast period. Growing burden of diseases and increasing adoption of minimally invasive surgeries is expected to propel the global nitinol medical devices market growth. Nitinol known for its super-elasticity, has wide number of applications in the healthcare...
The late stage chronic kidney disease drugs market was valued at US$ 4,680.0 million in 2019 and is projected to reach US$ 11,096.9 million by 2027; it is expected to grow at a CAGR of 11.6% during 2020–2027. The growth of the late stage chronic kidney disease drugs market is mainly attributed to the factors such as high prevalence...
Global Precision Medicine Market to Reach $278.61 Billion by 2030 Market Report Coverage - Precision Medicine Market Segmentation • By Ecosystem: Applied Sciences, Precision Diagnostics, Precision Therapeutics, Digital Health and IT • By Application: Cancer, Infectious Disease, Neurology, Cardiovascular,...
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.